2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Whole Cell Pertussis: new trials by email Literature Review of Whole Cell Pertussis trials Research Report on Whole Cell Pertussis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers GSK2036874A vaccine, Zilbrix™/Hib vaccine, Poliorix™ - Haemophilus Influenzae Type b, Tetanus | Phase 2 | Completed | GlaxoSmithKline | 312 | 2010-05-13 | 2019-10-01 |
| A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. DTPw-HBV/Hib-MenAC conjugate vaccine - Haemophilus Influenzae Type b, Tetanus | Phase 2 | Completed | GlaxoSmithKline | 450 | 2003-07-01 | 2016-09-09 |
Diphtheria (2) · Haemophilus Infections (2) · Hepatitis B (2) · Tetanus (2)
Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Blood-Borne Infections (2) · Clostridium Infections (2) · Communicable Diseases (2) · Corynebacterium Infections (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Gram-Negative Bacterial Infections (2) · Gram-Positive Bacterial Infections (2) · Hepadnaviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2)
GlaxoSmithKline (2)
Philippines (2)
2016 (1)